Palatin Technologies Inc (AMEX:PTN)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.90. At the close of
Assertio Holdings Inc (NASDAQ:ASRT)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 0.77. At the close of
Regenxbio Inc (NASDAQ:RGNX)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 1.29. At the close of trading,
Captivision Inc (NASDAQ:CAPT)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.43. At the close of trading,
Exagen Inc (NASDAQ:XGN)’s traded shares stood at 0.81 million during the last session, with the company’s beta value hitting 1.41. At the close of trading,
Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares stood at 0.75 million during the last session, with the company’s beta value hitting 0.56.The PHAT share’s 52-week high
Forge Global Holdings Inc (NYSE:FRGE)’s traded shares stood at 0.47 million during the last session, with the company’s beta value hitting 2.33. At the close
Immuneering Corp (NASDAQ:IMRX)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting -0.34. At the close of trading,
Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares stood at 0.66 million during the last session, with the company’s beta value hitting 2.56. At the close of
RenovoRx Inc (NASDAQ:RNXT)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 1.09. At the close of trading,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
